Promising Alzheimer’s therapy suggests alternative disease origin

Ed Park, MD age-related-diseases, alzheimer's, dr ed park, research Leave a Comment

Tip of the hat to my friend, Loren, who posted this article about an Australian team of researchers that improved mice Alzheimer’s by 75%

They used ultrasound beams to open up the blood-brain barrier, resulting in improved microglial clearance of the junk proteins associated with the disease. Microglial are the Praetorian guard macrophages of the central nervous system.

As we discussed in my interview with Dr. Michael Fossel, a medical doctor planning trials for telomerase gene therapy to treat Alzheimer’s, the microglia fail to do their job properly in Alzheimer’s and we discussed whether the problem isn’t that the microglia are relatively old and dysfunctional because you rarely get new recruits from the outside immune system that can enter unless there is brain inflammation. Some believe the majority of the microglia were there since you were an embryo.

Perhaps the better disease paradigm is that the inefficient clearance of bad cells and waste is a result of the evolutionary elegant design of the blood-brain barrier, which keeps the younger, more capable bone marrow-derived immune cells from entering this space.

To learn about telomeres and Alzheimer’s, listen to this interview that I did with Dr. Fossel:

Ed Park, MD

Ed Park, MD

I graduated from Harvard with honors in Biological Anthropology prior to earning my Medical Degree and Masters in Public Health from Columbia University.In 2007, I became the nineteenth patient to sign up for the use of a herbally-extracted telomerase activator.
The results were so positive that I founded Recharge Biomedical Clinic in 2008 and have since become the leading medical expert in this exciting new field of regenerative medicine.
I won The Houston Film Festival Award for my screenplay about Hypatia of Alexandria.
In 2013, I wrote and published "Telomere Timebombs; Defusing the Terror of Aging"
My websites are:
Ed Park, MD

Facebook Comments ()

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *